Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-16T13:16:55.734Z Has data issue: false hasContentIssue false

Lithium for suicide and readmission prevention after electroconvulsive therapy for unipolar depression: population-based register study

Published online by Cambridge University Press:  27 May 2019

Ole Brus*
Affiliation:
Statistician, Clinical Epidemiology and Biostatistics, Faculty of Medicine and Health, Örebro University, Sweden
Yang Cao
Affiliation:
Statistician, Clinical Epidemiology and Biostatistics, Faculty of Medicine and Health, Örebro University; and Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Sweden
Åsa Hammar
Affiliation:
Professor, Department of Biological and Medical Psychology, University of Bergen; and Division of Psychiatry, Haukeland University Hospital, Norway
Mikael Landén
Affiliation:
Professor, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at Gothenburg University; and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden
Johan Lundberg
Affiliation:
Physician and Associate Professor, Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet; and Stockholm County Council, Sweden
Pia Nordanskog
Affiliation:
Physician, Center for Social and Affective Neuroscience, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University; and Department of Psychiatry, Region Östergötland, Sweden
Axel Nordenskjöld
Affiliation:
Physician, University Health Care Research Centre, Faculty of Health and Medical Sciences, Örebro University, Sweden
*
Correspondence: Ole Brus, Klinisk epidemiologi och biostatistik, X-huset, Universitetssjukhuset ÖREBRO, 701 85 Örebro, Sweden. Email: ole.brus@regionorebrolan.se
Rights & Permissions [Opens in a new window]

Abstract

Background

Electroconvulsive therapy (ECT) is effective for unipolar depression but relapse and suicide are significant challenges. Lithium could potentially lower these risks, but is used only in a minority of patients.

Aims

This study quantifies the effect of lithium on risk of suicide and readmission and identifies factors that are associate with readmission and suicide.

Method

This population-based register study used data from the Swedish National Quality Register for ECT and other Swedish national registers. Patients who have received ECT for unipolar depression as in-patients between 2011 and 2016 were followed until death, readmission to hospital or the termination of the study at the end of 2016. Cox regression was used to estimate hazard ratios (HR) of readmission and suicide in adjusted models.

Results

Out of 7350 patients, 56 died by suicide and 4203 were readmitted. Lithium was prescribed to 638 (9%) patients. Mean follow-up was 1.4 years. Lithium was significantly associated with lower risk of suicide (P = 0.014) and readmission (HR 0.84 95% CI 0.75–0.93). The number needed to be treated with lithium to prevent one readmission was 16. In addition, the following factors were statistically associated with suicide: male gender, being a widow, substance use disorder and a history of suicide attempts. Readmission was associated with young age, being divorced or unemployed, comorbid anxiety disorder, nonpsychotic depression, more severe symptoms before ECT, no improvement with ECT, not receiving continuation ECT or antidepressants, usage of antipsychotics, anxiolytics or benzodiazepines, severity of medication resistance and number of previous admissions.

Conclusions

More patients could benefit from lithium treatment.

Declaration of interest

None.

Information

Type
Papers
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
Copyright © The Royal College of Psychiatrists 2019
Figure 0

Fig. 1Time to hospital readmission for patients using lithium after electroconvulsive therapy and those not using lithium, stratified by the number of earlier hospital admissions for psychiatric care.

Kaplan-Meier plot of differences in time to hospital readmission between patients collecting lithium and those who did not in total (a); and by the number of earlier hospital admissions for psychiatric disorders: (b) 0 admissions; (c) 1–20 admissions; (d) 21–140 admissions.
Supplementary material: File

Brus et al. supplementary material

Tables S1-S5

Download Brus et al. supplementary material(File)
File 43.3 KB
Submit a response

eLetters

No eLetters have been published for this article.